Further analyses should be performed to determine whether these new splicing sites could impact the splicing of BRCA1 or BRCA2 mRNA, for example with minigene experiments, but the systematic analysis of non‐coding sequences of cancer‐predisposing genes could improve the efficiency of molecular diagnosis. The gene discussed is BRCA1; the disease is cancer.